Table 4.
Multiple logistic regression exploring the association between ivermectin thrice and twice and seizure freedom during M9 to M12 of follow-up (group 2).
| Variables | OR | 95% CI | p-Value | |
|---|---|---|---|---|
| Ivermectin dose thrice vs twice | 0.477 | 0.196 | 1.125 | 0.107 |
| Female vs male | 0.871 | 0.347 | 2.131 | 0.772 |
| Age | 0.988 | 0.946 | 1.030 | 0.583 |
| Weight (in kg) | 0.990 | 0.941 | 1.041 | 0.713 |
| Seizure frequency at baseline | 0.823 | 0.458 | 1.462 | 0.527 |
| Duration of epilepsy (years) | 1.105 | 0.688 | 1.812 | 0.693 |
| Microfilarial density at baseline * | 0.739 | 0.573 | 0.934 | 0.018 |
| Optimal vs sub-optimal AED adherence during last four months | 2.792 | 1.141 | 7.281 | 0.034 |
| >30 mg of AED increase (between M0 and M12) vs no increase | 0.212 | 0.067 | 0.595 | 0.006 |
OR: Odds ratio; CI: Confidence interval; AED: Antiepileptic drug; *: Log-transformed.